Delivery Order SPE2DB20D3101-SPE2DB25FRRV0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tasigna 150 mg capsules (28-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract will be completed by September 2, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count packaging). This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 3, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the pharmaceutical product Tasigna 200 mg capsule. The order, valued at $5,624.62, has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of pharmaceuticals, medical supplies, and related distribution services in support of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of September 3, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count packaging) with a firm fixed price structure. This non-set-aside contract was awarded on July 30, 2025, with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction under the company's...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,638.02, is for the supply of the drug Tasigna 200 mg capsules. The order has an ultimate completion date of March 13, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of chronic myeloid leukemia, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, will be performed at the awardee's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of certain types of leukemia, reflecting...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $5,624.62, is for the supply of Tasigna 200 mg capsules. It is a firm fixed-price contract with an ultimate completion date of August 8, 2024. This award is not associated with any set-aside program. AmerisourceBergen, through its Corporate Office division, has been a significant supplier of...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRV0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 200 mg capsules (28-count units) under a firm fixed-price contract valued at $6,007.90. The award, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery against AmerisourceBergen's larger Indefinite Delivery Contract vehicle. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for federal medical procurement needs. This delivery order is executed under AmerisourceBergen's primary Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications and medical supplies to support military healthcare systems worldwide. The IDC supports critical federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, and positions AmerisourceBergen as a key vendor within the DLA's pharmaceutical supply chain serving defense and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/4/25 |